TY - JOUR
TI - Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings: Clinical presentation and management issues
AU - Bonaccorso, S.
AU - Metastasio, A.
AU - Ricciardi, A.
AU - Stewart, N.
AU - Jamal, L.
AU - Rujully, N.-U.-D.
AU - Theleritis, C.
AU - Ferracuti, S.
AU - Ducci, G.
AU - Schifano, F.
JO - Brain Sciences
PY - 2018
VL - 8
TODO - 7
SP - null
PB - MDPI AG
SN - -
TODO - 10.3390/brainsci8070133
TODO - amphetamine;  aripiprazole;  benzodiazepine;  cannabinoid;  cannabinoid receptor agonist;  clonazepam;  cocaine;  diamorphine;  haloperidol;  haloperidol decanoate;  lithium carbonate;  neuroleptic agent;  olanzapine;  pregabalin;  quetiapine;  risperidone;  valproic acid;  zuclopenthixol, adult;  aged;  aggression;  Article;  auditory hallucination;  case report;  clinical article;  drug dose increase;  drug screening;  drug substitution;  drug urine level;  female;  grandiose delusion;  human;  male;  mental health;  persecutory delusion;  Positive and Negative Syndrome Scale;  psychiatric intensive care unit;  psychosis;  retrospective study;  schizoaffective psychosis;  sexual dysfunction;  substance use;  urinalysis;  young adult
TODO - Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis is associated with SCRAs use. There is limited knowledge regarding the structured assessment and psychometric evaluation of clinical presentations, analytical toxicology and clinical management plans of patients presenting with psychosis and SCRAs misuse. Methods: We gathered information regarding the clinical presentations, toxicology and care plans of patients with psychosis and SCRAs misuse admitted to inpatients services. Clinical presentations were assessed using the PANSS scale. Vital signs data were collected using the National Early Warning Signs tool. Analytic chemistry data were collected using urine drug screening tests for traditional psychoactive substances and NPS. Results: We described the clinical presentation and management plan of four patients with psychosis and misuse of SCRAs. Conclusion: The formulation of an informed clinical management plan requires a structured assessment, identification of the index NPS, pharmacological interventions, increases in nursing observations, changes to leave status and monitoring of the vital signs. The objective from using these interventions is to maintain stable physical health whilst rapidly improving the altered mental state. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.
ER -